BEST-RPP
Active not recruiting
110 enrolled
ELEPHAS-04
Recruiting
324 enrolled
GENCONCOR-2
Recruiting
30 enrolled
ESCAPE
Completed
100,000 enrolled
Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)
Recruiting
1,500 enrolled
Retrospective Review of Esophageal Cancer at MSKCC
Recruiting
4,000 enrolled
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Recruiting
5,000 enrolled
MOMENTUM
Recruiting
8,000 enrolled
GASTROBRAIN
Active not recruiting
230 enrolled
Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging
Not yet recruiting
50 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Recruiting
80 enrolled
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Recruiting
60 enrolled
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
500 enrolled
PLATON
Terminated
565 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
MRinRT
Not yet recruiting
165 enrolled
iCaRe2
Recruiting
999,999 enrolled
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Active not recruiting
6,000 enrolled
OESOLUS
Completed
274 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
Precision Palliative Care for Patients With Advanced Esophageal Cancer
Recruiting
624 enrolled
ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients
Recruiting
700 enrolled
Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy
Active not recruiting
28 enrolled
Shanghai Clinical Cohort - Esophageal Cancer
Recruiting
2,116 enrolled
Impact of Arterial Partial Pressure of Oxygen on Anastomotic Leakage After Esophagectomy
Completed
2,083 enrolled
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
Recruiting
56 enrolled
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Recruiting
100 enrolled
BE
Active not recruiting
600 enrolled
EsophaCap for the Detection of Early Esophageal Carcinoma
Recruiting
2,500 enrolled
FAISA-CORPPS
Completed
30 enrolled
AROMA2
Not yet recruiting
6,000 enrolled
Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer
Recruiting
200 enrolled
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Recruiting
320 enrolled
BLISS
Recruiting
3,156 enrolled
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Recruiting
700 enrolled
Perioperative Outcomes and Survival of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy for Selected Esophageal Cancer
Completed
1,661 enrolled
ST-ICI02
Recruiting
200 enrolled
Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort Study
Not yet recruiting
200 enrolled
Incidence of 107 Lymph Node Metastasis
Recruiting
1,100 enrolled
Incidence of 106TBL Lymph Node Metastasis
Recruiting
1,852 enrolled
SEISMIC
Not yet recruiting
164 enrolled
AMCOR
Recruiting
30 enrolled
ESCAPE
Recruiting
66 enrolled
RECAP
Active not recruiting
47,000 enrolled
FBE
Recruiting
2,000 enrolled
Non-gastric Conduit Reconstruction After Esophagectomy
Not yet recruiting
25 enrolled
The Diagnostic Value of Nitrogen Element (N) in Esophagus Cancer
Completed
120 enrolled
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
Recruiting
150 enrolled
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Recruiting
30 enrolled